ArticleCureus2025
Traumatic Anserine Folliculosis: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Traumatic anserine folliculosis (TAF) is a rare, under-recognized dermatological condition caused by repeated friction or pressure. This leads to grouped follicular papules with a rough, sandpaper-like texture, most commonly on the face or neck. It primarily affects adolescents and young adults, with pathogenesis linked to mechanical irritation causing follicular hyperkeratosis and keratin plug formation. We report the case of a young male who developed hyperpigmented follicular papules on his left cheek with a history of resting his cheek on his palm. Clinical evaluation confirmed TAF, and treatment with topical retinoids and keratolytics, along with avoidance of friction, led to marked improvement after nine months. The diagnosis of TAF is clinical and relies on recognizing the frictional history and characteristic lesions, distinguishing it from conditions like keratosis pilaris (KP) and lichen spinulosus. Management centers on educating patients, eliminating trauma, and using topical retinoids or keratolytics, with generally excellent outcomes when identified and treated early.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.